Top Suppliers:I want be here

1464842-09-8

1464842-09-8 structure
1464842-09-8 structure
  • Name: M8891
  • Chemical Name: M8891
  • CAS Number: 1464842-09-8
  • Molecular Formula: C20H17F2N3O3
  • Molecular Weight: 385.36
  • Catalog: Research Areas Cancer
  • Create Date: 2020-01-23 09:58:51
  • Modify Date: 2025-08-27 17:04:13
  • M8891 is an orally active, reversible and brain penetrant Methionine Aminopeptidase-2 (MetAP-2) inhibitor with an IC50 of 54 nM and a Ki of 4.33 nM. M8891 does not inhibit MetAP-1 (IC50>10 µM)[1]. M8891 inhibits growth of primary endothelial cells as well as tumor cells and demonstrates antiangiogenic and antitumoral activity[2].

Name M8891
Description M8891 is an orally active, reversible and brain penetrant Methionine Aminopeptidase-2 (MetAP-2) inhibitor with an IC50 of 54 nM and a Ki of 4.33 nM. M8891 does not inhibit MetAP-1 (IC50>10 µM)[1]. M8891 inhibits growth of primary endothelial cells as well as tumor cells and demonstrates antiangiogenic and antitumoral activity[2].
Related Catalog
Target

IC50: 54 nM (MetAP-2)[1] Ki: 4.33 nM (MetAP-2)[1]

In Vitro M8891 has an IC50 of 20 nM for HUVEC proliferation[1].
In Vivo M8891 (po; 20 mg/kg; once a day for 14 days) exhibits strong tumor growth inhibition[1]. M8891 (iv; 0.2 mg/kg) shows low clearance (CL ~0.03-0.4 L/h/kg corresponding to ~1-6% of the liver blood-flow), small to medium volume of distribution (Vss ~0.23-1.3 L/kg), and medium to high oral bioavailability (F ~40-80%)[1]. Animal Model: Female CD-1 nude mice aged 6-7 weeks with human U87-MG glioblastoma[1] Dosage: 20 mg/kg Administration: Po; once a day for 14 days Result: Exhibited strong tumor growth inhibition. Animal Model: Rat, dog and monkey[1] Dosage: 0.2 mg/kg (Pharmacokinetic Analysis) Administration: IV Result: Showed low clearance (CL ~0.03-0.4 L/h/kg corresponding to ~1-6% of the liver blood-flow), small to medium volume of distribution (Vss ~0.23-1.3 L/kg), and medium to high oral bioavailability (F ~40-80%).
References

[1]. Heinrich T, et al. Identification of Methionine Aminopeptidase-2 (MetAP-2) Inhibitor M8891: A Clinical Compound for the Treatment of Cancer. J Med Chem. 2019 Dec 26;62(24):11119-11134.

[2]. Manja Friese-Hamim, et al. Abstract 3075: Antitumor activity of M8891, a potent and reversible inhibitor of methionine aminopeptidase 2.

Molecular Formula C20H17F2N3O3
Molecular Weight 385.36
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.